George Magrath

Insider Reports History

Location
37000 Grand River Ave, Suite 120, Farmington Hills, MI
Signature
/s/ Sharon Goldbach, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Magrath:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Opus Genetics, Inc. Chief Executive Officer, Director Common Stock 1.32M $1.52M $1.15 Mar 24, 2025 Direct
Opus Genetics, Inc. Chief Executive Officer, Director Warrants (right to buy) 392K Mar 24, 2025 Direct
Opus Genetics, Inc. Chief Executive Officer, Director Employee Stock Option (right to buy) 331K Mar 13, 2025 Direct

Insider Reports Filed by George Magrath

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IRD Opus Genetics, Inc. Mar 24, 2025 2 $0 4 Mar 26, 2025 Chief Executive Officer, Director
IRD Opus Genetics, Inc. Mar 13, 2025 2 $0 4 Mar 17, 2025 Chief Executive Officer
IRD Opus Genetics, Inc. Dec 26, 2024 1 $97.6K 4 Dec 30, 2024 Chief Executive Officer
IRD Opus Genetics, Inc. Dec 23, 2024 1 $0 4 Dec 23, 2024 Chief Executive Officer
IRD Opus Genetics, Inc. Nov 15, 2024 2 $101K 4 Nov 19, 2024 Chief Executive Officer
IRD Opus Genetics, Inc. Nov 1, 2024 1 -$43.7K 4 Nov 5, 2024 Chief Executive Officer
OCUP Ocuphire Pharma, Inc. May 17, 2024 1 $8.77K 4 May 21, 2024 Chief Executive Officer
OCUP Ocuphire Pharma, Inc. Mar 18, 2024 1 $49.1K 4 Mar 20, 2024 Chief Executive Officer
OCUP Ocuphire Pharma, Inc. Nov 1, 2023 2 $0 4 Nov 3, 2023 Chief Executive Officer
OCUP Ocuphire Pharma, Inc. Nov 1, 2023 0 $0 3 Nov 3, 2023 Chief Executive Officer